Breakthrough in Colon Cancer Treatment: Novel Nanoparticle Technology

Researchers at King Khalid University have developed a revolutionary new drug delivery system for treating colon cancer, utilizing nanoparticles made from cross-linked mastic gum. This novel approach aims to enhance treatment efficacy while minimizing systemic side effects. The findings were published in the journal Scientific Reports, a leading international scientific publication.

Key Takeaways:

• The researchers employed Fourier Transform Infrared Radiation (FTIR) and Scanning Electron Microscopy (SEM) to characterize the nanoparticles, confirming successful cross-linking and uniform morphology.
• The nanoparticles effectively encapsulated and controlled the release of 5-fluorouracil (5-FU), a common chemotherapy drug, with an efficiency of 83.53% and a release percentage of 95.20%.
• The particle size was found to be 240 nm, and the drug release kinetics was zero-order, indicating a sustained release of the drug over time.
• The study recommends the proposed drug delivery system for improving the outcomes of colon cancer treatment.
• The research was conducted by a team of experts, including Umme Hani, Nawaz Mahammed, T. Reshma, Sirajunisa Talath, Adil Farooq Wali, Abdullah Aljasser, Adel Al Fatease, Ali H. Alamri, and Sharuk Khan.

Statistics:

• 83.53% drug encapsulation efficiency
• 240 nm particle size
• 95.20% drug release percentage
• Zero-order drug release kinetics
• 5-fluorouracil (5-FU) as the chemotherapy drug used in the study
• Colon cancer treatment improvement as the primary goal of the research

Sources:

• "Enhanced colon-targeted drug delivery through development of 5-fluorouracil-loaded cross-linked mastic gum nanoparticles" (2025) Scientific Reports, Published online June 9, 2025.
• Nature Publishing Group
• Scientific Reports (www.nature.com/srep)
• King Khalid University
• Nature Portfolio (www.nature.com/)